Can theobromine cause tachycardia and insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Theobromine Cause Tachycardia and Insomnia?

Yes, theobromine can cause both tachycardia and insomnia, particularly at higher doses, though these effects are dose-dependent and generally occur at intakes well above typical dietary consumption from chocolate.

Cardiovascular Effects: Tachycardia

Theobromine dose-dependently increases heart rate, with this effect becoming clinically significant at higher doses 1:

  • At normal dietary intake ranges (approximately 250 mg or less), theobromine shows limited cardiovascular effects 1
  • At doses of 500-1,000 mg, theobromine produces measurable increases in heart rate 1
  • Theobromine primarily affects the cardiovascular system through its methylxanthine properties, acting as a competitive antagonist of adenosine receptors 2

Clinical Context and Arrhythmia Risk

  • In individuals with underlying cardiac substrate (such as atrioventricular nodal reentry pathways), large amounts of chocolate consumption containing theobromine can precipitate supraventricular tachycardia 2
  • The arrhythmogenic potential stems from theobromine's adenosine receptor antagonism, similar to but less potent than caffeine 2
  • In animal toxicology (dogs), theobromine poisoning manifests with tachycardia, cardiac arrhythmias, and can progress to seizures and death, though these effects occur at doses (100-500 mg/kg) far exceeding human dietary exposure 3

Central Nervous System Effects: Insomnia and Hyperexcitability

Theobromine affects the central nervous system in a dose-dependent manner, though its CNS penetration is less pronounced than caffeine 4:

  • At low doses (250 mg), theobromine shows limited subjective CNS effects 1
  • At higher doses (500-1,000 mg), theobromine produces negative mood effects rather than the alertness associated with caffeine 1
  • In animal models, theobromine increases ambulatory activity at 10 mg/kg, indicating CNS stimulation 5
  • The mechanism involves methylxanthine-mediated effects on the central nervous system, though theobromine is less potent than caffeine in producing wakefulness 4

Comparison to Caffeine

  • Caffeine (200 mg) produces expected increases in alertness and feelings of wakefulness, effects that are more pronounced than equivalent doses of theobromine 1
  • While caffeine is the more convincing psychopharmacological agent in chocolate, a role for theobromine in CNS stimulation cannot be ruled out 4
  • The combination of caffeine and theobromine in chocolate products may produce additive effects on heart rate and sleep disturbance 2

Dose-Response Relationship and Practical Implications

The key clinical consideration is the dose consumed:

  • Typical dietary intake: A standard serving of dark chocolate (10 g at 70% cocoa) contains approximately 15-20 mg of theobromine 6, well below the threshold for significant cardiovascular or CNS effects
  • Moderate consumption: 100 g of plain chocolate contains approximately 1,500 mg of theobromine 3, approaching doses that produce measurable heart rate increases in humans 1
  • High consumption: Doses of 500-1,000 mg (equivalent to 50-100 g of dark chocolate) begin to produce negative subjective effects and tachycardia 1

Absorption Kinetics

  • Theobromine absorption from chocolate is relatively rapid, with peak plasma concentrations occurring approximately 2 hours after consumption 7
  • Plasma theobromine levels from chocolate can reach 8.05 μg/mL after consuming 370 mg, which may produce behaviorally discriminable effects in some individuals 7
  • The half-life of theobromine in humans is 2-3 hours, considerably shorter than in dogs (18 hours) 3

Clinical Recommendations

For patients reporting palpitations or sleep disturbance after chocolate consumption:

  1. Quantify intake: Determine the amount and type of chocolate consumed (dark chocolate contains 15-20 mg/g theobromine; milk chocolate contains 2 mg/g) 3, 6
  2. Assess timing: Symptoms typically appear within 2 hours of ingestion, corresponding to peak plasma levels 7
  3. Evaluate underlying risk: Screen for pre-existing arrhythmia substrates, as theobromine can precipitate tachycardia in susceptible individuals 2
  4. Recommend dose reduction: Limit chocolate intake to ≤10 g/day of dark chocolate to stay within the range associated with cardiovascular benefits without adverse effects 6

Special Populations at Risk

Individuals with arrhythmia history should limit cacao consumption to 6-7 g/day because theobromine and caffeine are CNS stimulants that raise heart rate and increase susceptibility to cardiac arrhythmias 6. Those sensitive to caffeine may experience elevated blood pressure, increased heart rate, and sleep interference even at lower theobromine doses 6.

Common Pitfalls

  • Underestimating cumulative methylxanthine load: Patients consuming both coffee and chocolate receive additive effects from caffeine and theobromine 2
  • Ignoring individual variability: Some individuals are more sensitive to methylxanthine effects, experiencing symptoms at lower doses 1
  • Dismissing symptoms: While rare at typical dietary intakes, high chocolate consumption can produce clinically significant tachycardia and should not be dismissed 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Theobromine and the pharmacology of cocoa.

Handbook of experimental pharmacology, 2011

Research

Behavioral effects of cocoa and its main active compound theobromine: evaluation by ambulatory activity and discrete avoidance in mice.

Arukoru kenkyu to yakubutsu izon = Japanese journal of alcohol studies & drug dependence, 1992

Guideline

Heart-Healthy Chocolate Consumption

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Absorption rate of methylxanthines following capsules, cola and chocolate.

European journal of clinical pharmacology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.